Methods of treating Factor VIIa-associated conditions in a mammal are described, comprising administering to the mammal in need of treatment thereof an effective amount of at least one compound having the formula (I), ##STR1##

or a pharmaceutically-acceptable salt, hydrate or prodrug thereof.